Last Modified: January 20, 2013
Constipation is a decrease in the number of daily bowel movements and/or the difficult passage of hard stool. It may cause discomfort or bleeding from the rectum. Constipation may be caused by decreased fluid and/or food intake, decreased activity, some medications, cancer treatments (chemotherapy), and/or cancers of the digestive system.
The signs and symptoms of constipation include:
It is important to call at the first signs of any problem so that the constipation can be managed more easily with the least amount of interventions and so that complications do not occur.
Call your doctor if you have any of the following:
Treatment of constipation will depend on its cause. Your doctor or nurse may recommend a bowel regimen using stool softeners and/or laxatives. Stool softeners (such as docusate sodium or Colace) work by bringing water into the stool, making it softer and easier to pass. A stimulant or laxative (such as Bisacodyl, Dulcolax, or Senakot) works by stimulating peristalsis, moving the stool through the bowel. For occasional or difficult to manage constipation your doctor or nurse may recommend Miralax (Polyethylene glycol 3350). Miralax is a different type of laxative called an osmotic laxative. It works by causing water to be retained in the stool, softening the stool so it is easier to pass. These medications can be taken together. There are even some preparations combining stool softeners and laxatives in one pill, such as Senakot-S.
If you have persistent problems with constipation, consider taking softeners and/or a stimulant every day, per the package dosing instructions. Do not use enemas unless instructed by your doctor or nurse. If you do not have a bowel movement in 3 or more days, talk with your doctor or nurse about a stronger regimen. If you have any questions about constipation or need additional information, ask your doctor or nurse.
Oct 4, 2011 - Treatment of localized prostate cancer using intensity modulated radiation therapy is associated with a considerable reduction in late bowel and rectal side effects and significantly decreased rectal and bladder toxicity compared to three-dimensional conformal radiation therapy, according to a study presented the annual meeting of the American Society for Radiation Oncology, held from Oct. 2 to 6 in Miami Beach.
Nov 22, 2014
Nov 22, 2014